Please login to the form below

Not currently logged in
Email:
Password:

RotaTeq

This page shows the latest RotaTeq news and features for those working in and with pharma, biotech and healthcare.

Sanofi unit takes low-cost rotavirus vaccine into phase III

Sanofi unit takes low-cost rotavirus vaccine into phase III

and Merck &Co's RotaTeq which, while effective, are still unaffordable for many countries battling with the infection. ... III trials, promising to make it available at around one-tenth the price of Rotarix and RotaTeq.

Latest news

  • GSK's Rotarix vaccine resumes use in US

    They suggested doctors use Merck's RotaTeq vaccine instead. . On Friday (May 14, 2010), the agency reversed its decision, saying there is no evidence that porcine circovirus can infect or sicken

  • Virus found in GSK's Rotarix vaccine

    Preliminary testing on Merck's RotaTeq, another rotavirus vaccine, has found no traces of PCV1.

  • WHO recommends rotavirus vaccines

    Data on Merck's rotavirus vaccine, RotaTeq, from clinical trials in Bangladesh, Vietnam, Ghana, Mali, and Kenya are expected in the autumn.

  • GSK's Rotarix protects against commonest rotaviruses

    The company has already obtained EU marketing approval. However, Merck &Co's RotaTeq was approved in the US in February 2007, and an advisory committee of the US Centers for Disease ... Control and Prevention (CDC) recently voted to recommend that all

  • Pharma news in brief

    Last month, Merck's rival Rotateq vaccine gained US Food and Drug Administration (FDA) approval as well as a Centers for Disease Control recommendation that it would be reimbursable by the

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics